Prevention of cerebral vasospasm after experimental subarachnoid hemorrhage by the endothelin-receptor-antagonist RO 47-0203;Pravention zerebraler Vasospasmen nach experimenteller Subarachnoidalblutung durch den Endothelin-Rezeptorantagonisten RO 47-0203

Zentralblatt fur Neurochirurgie

Volumn 57, Issue 3, 1996, Pages 143-149

  Zimmermann, M ^a   Seifert, V ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

cerebral atrial spasm; endothelin 1; endothelin receptor inhibitor; two hemorrhage model

Indexed keywords

BOSENTAN; ENDOTHELIN RECEPTOR ANTAGONIST; ENDOTHELIN; ENDOTHELIN RECEPTOR; SULFONAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASILAR ARTERY; BRAIN VASOSPASM; CONTROLLED STUDY; DOG; INTRAARTERIAL DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; SUBARACHNOID HEMORRHAGE; ANIMAL; BRAIN ANGIOGRAPHY; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG ANTAGONISM; DRUG EFFECT; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSIENT ISCHEMIC ATTACK; VASCULAR RESISTANCE;

ANIMALS; BASILAR ARTERY; CEREBRAL ANGIOGRAPHY; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENDOTHELINS; INFUSIONS, INTRA-ARTERIAL; ISCHEMIC ATTACK, TRANSIENT; RECEPTORS, ENDOTHELIN; SUBARACHNOID HEMORRHAGE; SULFONAMIDES; VASCULAR RESISTANCE;

EID: 0029665426     PISSN: 00444251     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Asano T, Ikegaki I, Susuki Y, Satoh S, Satoh S, Shibuya M: Endothelin and the production of vasospasm in dogs. Biochem Biophys Res Commun 159 (1989) 1345-1351.
2. Breu V, Löffler BM, Clozel M: In vitro characterisation of RO 46-2005, a novel synthetic non-peptide endothelin antagonist of ETA and ETB receptors. FEBS Lett 334 (1993) 210-214.
3. Chabrier PE, Braquet P: Endothelin. Horm Res 34 (1990) 169-174.
4. Clozel M, Watanabe H: BQ-123, a peptidic endothelin receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection. Life Sci 52 (1992) 825-834.
5. Clozel M, Breu V, Burri K, Cassel JM, Fischli W, Gray GA, Hirth G, Löffler BM, Müller M, Neidhart W, Ramuz H: Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature 365 (1993) 759-761.
6. Clozel M, Breu Y, Gray GA, Kalina B, Löffler BM, Burri K, Cassal JM, Hirth G, Müller M, Neidhart W, Ramuz H: Pharmacological characterisation of bosentan, a new potent orally active non-peptidic endothelin receptor antagonist. J Pharmacol Exp Ther 270 (1994) 228-235.
7. Cocks T, Malta E, King S, Woods R, Angus J: Oxyhaemoglobin increases the production of endothelin-1 by endothelial cells in culture. Europ J Pharmacol 196 (1991) 177-182.
8. Ehrenreich H, Kehrl JH, Anderson W, Rieckmann P, Vitkovic L, Coligan JE, Fauci AS: A vasoactive peptide, endothelin-3, is produced by and specifically binds to primary astrocytes. Brain Res 538 (1991) 54-58.
9. Fujiwara S, Kassel NF, Sasaki T, Nakagomi T, Lehman RM: Selective hemoglobin inhibition of endothelium-dependent vasodilation of rabbit basilar artery. J Neurosurg 64 (1986) 445-452.
10. Giaid A, Gibson SJ, Ibrahim NB, Legon S, Bloom SR, Yanagisawa M, Masaki T, Varndell IM, Polak JM: Endothelin-1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and the dorsal root ganglia. Proc Natl Acad Sci 86 (1989) 7634-7638.
11. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T: The human endothelin family: Three structurally and pharmacologially distinct isopeptides predicted by three seperate genes. Proc Natl Acad Sci 86 (1989) 2863-2867.
12. Juvela S, Hillbom M, Kaste M: Platelet thromboxane release and delayed cerebral ischemia in patients with subarachnoid hemorrhage. J Neurosurg 74 (1991) 386-392.
13. Kassel NF, Torner JC, Haley EC, Jane JA, Adams HP, Kongable GL: The international cooperative studa on the timing of aneurysm surgery. Part 1: Overall management results. J Neurosurg 73 (1990) 18-36.
14. Kasuya H, Weir BKA, White DM, Stefanson K: Mechanism of oxyhemoglobin-induced release of endothelin-1 from cultured vascular endothelial cells and smooth muscle cells. 79 (1993) 892-898.
15. Kobayashi H, Hayashi M, Kobayashi S, Kabuto M, Handa Y, Kawano H: Effect of endothelin on the canine basilar arteriy. Neurosurgery 27 (1990) 357-361.
16. Liszcak TM, Black PM, Tzouras A, Foley L, Zervas NT: Morphological changes of the basilar artery, vertricles and choroid plexus after experimental SAH. J Neurosurg 61 (1984) 486-493.
17. Löffler BM, Maire JP: Radioimmunological determination of endothelin peptides in human plasma: A methodological approach. Endothelium 1 (1994) 273-286.
18. MacCumber MW, Ross CA, Snyder SH: Endothelin in brain: Receptors, mitogenesis and biosynthesis in glial cells. Proc Natl Acad Sci 87 (1990) 2359-2363.
19. Matsumura Y, Ikegawa R, Susuki Y, Takaoka M, Uchida T, Kido H, Shinyama H, Hayaschi K, Watanabe K, Morimoto S: Phosphoramidon prevents cerebral vasospasm following subarachnoid hemorrhage in dogs: the relationdhip to endothelin-I levels in the cerebrospinal fluid. Life Sci 49 (1991) 841-848.
20. Nirei H, Hamada K, Shoubo M, Sogabe K, Notsu Y, Ono T:. An endothelin ET-A receptor antagonist, Fr 139317, ameliorates cerebral vasospasm in dogs. Life Sci 52 (1993) 1869-1874.
21. 2 in cerebral arteries of the monkey. Neurosurgery 22 (1988) 45-50.
22. Papadopoulos S, Gilbert L, Webb C, Amato C: Characterization of contractile responses to endothelin in human cerebral arteries: Implications for cerebral vasospasm. Neurosurgery 26 (1990) 810-815.
23. Seifert V, Stolke D, Kaever Y, Dietz H: Arachnoidonic acid metabolism following aneurysm rupture. Surg Neurol 27 (1987) 243-252.
24. Seifert V, Eisert W, Stolke D, Goetz C: Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage. Neurosurgery 25 (1989) 590-598.
25. Seifert, V., Löffler, B. M., Zimmermann, M., Roux, S., Stolke, D.: Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage: Correlation with cerebral vasospasm, delayed ischemic neurological deficits and volume of hematoma. J Neurosurg 82 (1995) 55-62.
26. Shigeno T, Mina T, Yanagisawa M, Saito A, Goto K, Yamashita K, Takenoushi T, Matsuura N, Yamasaki Y, Yamada K, Masaki T, Takakura K: Prevention of cerebral vasospasm by actinomycin D. J Neurosurg 74 (1991) 940-943.
27. Shiyama H, Uchida T, Kido H, Hayashi K, Watanabe M, Matsumara Y, Ikegawa R, Takaoka M, Morimoto S: Phosphoramidon inhibits the conversion of intracisternally administrated big endothelin to endothelin-1. Biochem Biophys Res Commun 178 (1991) 24-30.
28. Susuki R, Masaoka E, Hirata H, Marumo F, Isotani E, Hirakawa K: The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 77 (1992) 96-100.
29. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kabayashi M, Mitsui Y, Yazaka Y, Goto K, Masaki T: A vovel potent vasoconstrinctor peptide produced by the vaskular endothelial cells. Nature 332 (1988) 411-415.
30. Zimmermann M, Seifert V, Löffler BM, Roux S, Stolke D: The role of big-endothelin-1, endothelin-1 and endothelin-3 in the development of cerebral vasospasm and ischemic neurological deficits after aneurysmal subarachnoid hemorrhage. Zentralbl Neurochir (Supplement) 45 (1994) 82.